Lv61
1842 积分 2024-07-04 加入
Promising phase II biologics for future Crohn's disease therapy
2天前
已完结
Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triple-negative breast cancer: real-world data from the Neo-Real/GBECAM 0123 study
2个月前
已完结
Fuzuloparib with or without apatinib in patients with HER2-negative metastatic breast cancer with germline BRCA1/2 mutations (FABULOUS): interim analysis of a multicentre, three-arm, open-label, randomised, phase 3 trial
2个月前
已完结
Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triple-negative breast cancer: real-world data from the Neo-Real/GBECAM 0123 study
2个月前
已关闭
ABC8 Consensus: Assessment by a German Group of Experts
2个月前
已完结
Sacituzumab Govitecan in Untreated, Advanced Triple-Negative Breast Cancer
2个月前
已完结
Clinical and molecular biomarkers for prediction of endocrine response after short preoperative endocrine therapy in the WSG ADAPT-HR+/HER2- and ADAPTcycle trials (N=7914)
2个月前
已完结
Effect of immunotherapy or anti-angiogenesis therapy combined with chemotherapy for advanced triple-negative breast cancer: A real-world retrospective study
3个月前
已关闭
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
3个月前
已完结
早期乳腺癌前哨淋巴结活检手术 临床实践指南（2025版）
3个月前
已完结
皖公网安备34019202002308
